Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 727

1.

Risk of diabetes mellitus associated with atypical antipsychotic use among Medicaid patients with bipolar disorder: a nested case-control study.

Guo JJ, Keck PE Jr, Corey-Lisle PK, Li H, Jiang D, Jang R, L'Italien GJ.

Pharmacotherapy. 2007 Jan;27(1):27-35.

PMID:
17192159
2.

Risk of diabetes mellitus associated with atypical antipsychotic use among patients with bipolar disorder: A retrospective, population-based, case-control study.

Guo JJ, Keck PE Jr, Corey-Lisle PK, Li H, Jiang D, Jang R, L'Italien GJ.

J Clin Psychiatry. 2006 Jul;67(7):1055-61.

PMID:
16889448
3.

Assessment of antipsychotic-related risk of diabetes mellitus in a Medicaid psychosis population: sensitivity to study design.

Gianfrancesco F, Pesa J, Wang RH, Nasrallah H.

Am J Health Syst Pharm. 2006 Mar 1;63(5):431-41.

PMID:
16484517
4.

Antipsychotic exposure and type 2 diabetes among patients with schizophrenia: a matched case-control study of California Medicaid claims.

Lambert BL, Chou CH, Chang KY, Tafesse E, Carson W.

Pharmacoepidemiol Drug Saf. 2005 Jun;14(6):417-25.

PMID:
15786516
5.

Comparative study of the development of diabetes mellitus in patients taking risperidone and olanzapine.

Fuller MA, Shermock KM, Secic M, Grogg AL.

Pharmacotherapy. 2003 Aug;23(8):1037-43.

PMID:
12921249
6.

Medication patterns and costs associated with olanzapine and other atypical antipsychotics in the treatment of bipolar disorder.

Zhu B, Kulkarni PM, Stensland MD, Ascher-Svanum H.

Curr Med Res Opin. 2007 Nov;23(11):2805-14.

PMID:
17910804
7.

Comparing adherence to and persistence with antipsychotic therapy among patients with bipolar disorder.

Hassan M, Madhavan SS, Kalsekar ID, Makela EH, Rajagopalan K, Islam S, Kavookjian J, Miller LA.

Ann Pharmacother. 2007 Nov;41(11):1812-8. Epub 2007 Oct 9.

PMID:
17925501
8.
9.

Time to psychiatric hospitalization in patients with bipolar disorder treated with a mood stabilizer and adjunctive atypical antipsychotics: a retrospective claims database analysis.

Kim E, Maclean R, Ammerman D, Jing Y, Pikalov A, You M, Van-Tran Q, L'Italien G.

Clin Ther. 2009 Apr;31(4):836-48. doi: 10.1016/j.clinthera.2009.04.022.

PMID:
19446157
10.

Atypical antipsychotic drugs and diabetes mellitus in a large outpatient population: a retrospective cohort study.

Østbye T, Curtis LH, Masselink LE, Hutchison S, Wright A, Dans PE, Schulman KA, Krishnan RR.

Pharmacoepidemiol Drug Saf. 2005 Jun;14(6):407-15.

PMID:
15372671
11.

Treatment adherence among patients with bipolar or manic disorder taking atypical and typical antipsychotics.

Gianfrancesco FD, Rajagopalan K, Sajatovic M, Wang RH.

J Clin Psychiatry. 2006 Feb;67(2):222-32.

PMID:
16566617
12.

Differential effects of antipsychotic agents on the risk of development of type 2 diabetes mellitus in patients with mood disorders.

Gianfrancesco F, Grogg A, Mahmoud R, Wang RH, Meletiche D.

Clin Ther. 2003 Apr;25(4):1150-71.

PMID:
12809963
13.
14.

Comparison of second-generation antipsychotic treatment on psychiatric hospitalization in Medicaid beneficiaries with bipolar disorder.

Jing Y, Johnston SS, Fowler R, Bates JA, Forbes RA, Hebden T.

J Med Econ. 2011;14(6):777-86. doi: 10.3111/13696998.2011.625066. Epub 2011 Sep 29.

PMID:
21954966
15.

Patterns of discontinuation of atypical antipsychotics in the province of Québec: A retrospective prescription claims database analysis.

Moisan J, Grégoire JP.

Clin Ther. 2010;32 Suppl 1:S21-31. doi: 10.1016/j.clinthera.2010.01.003.

PMID:
20152549
16.

Hospitalization risks in the treatment of bipolar disorder: comparison of antipsychotic medications.

Gianfrancesco F, Rajagopalan K, Goldberg JF, Wang RH.

Bipolar Disord. 2007 May;9(3):252-61.

PMID:
17430300
17.

Diabetes mellitus and antipsychotic treatment in the United Kingdom.

Carlson C, Hornbuckle K, DeLisle F, Kryzhanovskaya L, Breier A, Cavazzoni P.

Eur Neuropsychopharmacol. 2006 Jul;16(5):366-75. Epub 2005 Dec 13.

PMID:
16356695
18.

Clozapine use in patients with schizophrenia and the risk of diabetes, hyperlipidemia, and hypertension: a claims-based approach.

Lund BC, Perry PJ, Brooks JM, Arndt S.

Arch Gen Psychiatry. 2001 Dec;58(12):1172-6.

PMID:
11735847
20.

Diagnoses associated with use of atypical antipsychotics in a commercial health plan: a claims database analysis.

Citrome L, Kalsekar I, Guo Z, Laubmeier K, Hebden T.

Clin Ther. 2013 Dec;35(12):1867-75. doi: 10.1016/j.clinthera.2013.09.006. Epub 2013 Oct 8.

Items per page

Supplemental Content

Write to the Help Desk